Results of the first 6 months' experience in the monitoring of the sterility of injectable solutions
Pappalardo, G.
Revue Medicale de la Suisse Romande 106(2): 163-171
1986
ISSN/ISBN: 0035-3655 PMID: 3515496 Document Number: 269415
Document emailed within 1 workday
Related Documents
Mayhall, C.G.; Pierpaoli, P.G.; Hall, G.O.; Thomas, R.B. 1981: Evaluation of a device for monitoring sterility of injectable fluids American Journal of Hospital Pharmacy 38(8): 1148-1150Montanari, L.; Pavanetto, F.; Ponci, R. 1983: Foreign particle contamination in high volume injectable solutions and in powders for injectable solutions. Proposals for an Italian standard Il Farmaco; Edizione Pratica 37(12): 397-407
Zathurecky, L.; Bauerova, O.; Somoskeoey, G.; Molnar, L.; Suchy, S. 1963: Stability of Cardenolides of the Strophanthidin type in Injectable Preparations. Iii. Preparations of Stable Injectable Solutions of Helveticoside Ceskoslovenska Farmacie 12: 171-177
Rossi, P.; Maccioni, F.; Salvatori, F.M.; Bezzi, M.; Gandini, R.; Broglia, L.; Ingianna, D. 1994: Transjugular intrahepatic portosystemic shunt (TIPS): indications and results after 22 months of experience La Radiologia Medica 87(5): 585-596
Meyer, K.H.; Bickel, H. 1977: Ensuring the sterility of infusion solutions Klinische Anasthesiologie und Intensivtherapie 14: 18-20
Mardoñ, K.; Olakowski, T. 1971: BCG vaccination using intradermal Akra injector. III. Results of measurements of post-vaccination scars 12 months after vaccination and comparison of results after 6 and 12 months Gruzlica i Choroby Pluc; Tuberculosis et Pneumonologia 39(11): 1063-1071
Kachala, V.P.; Il'nitskaia, Z.N. 1971: Incompatibility of injectable drug solutions in the same syringe Meditsinskaia Sestra 30(5): 33-36
World-Health-Organization-Collaborative-Study-Of-Cardiovascular-Disease-And-Steroid-Hormone-Contraception 1998: Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives: Results of an international, multicenter, case-control study Contraception 57(5): 315-324
World-Health-Organization-Collaborative-Study-Of-Cardiovascular-Disease-And-Steroid-Hormone-Contraception 1998: Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives: Results of an international, multicenter, case-control study Contraception 57(5): 315-324
Haustein, K.O.; Winkler, U. 1989: Therapeutic drug monitoring of digitoxin--results of 3 years' experience Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 44(21): 640-643
Ammar, H.O.; Ibrahim, S.A.; Abd El-Mohsen, M.G. 1982: Effect of chelating agents on the stability of injectable isoniazid solutions Die Pharmazie 37(4): 270-271
Trissel, L.A.; Pearson, S.D. 1994: Storage of lorazepam in three injectable solutions in polyvinyl chloride and polyolefin bags American Journal of Hospital Pharmacy 51(3): 368-372
McGuire, T.R.; Narducci, W.A.; Fox, J.L. 1993: Compatibility and stability of ondansetron hydrochloride, dexamethasone, and lorazepam in injectable solutions American Journal of Hospital Pharmacy 50(7): 1410-1414
Montanari, L.; Pavanetto, F.; Signoretti Ciranni, E. 1983: Contamination by extraneous particles of injectable solutions of plasma substitutes and iodinated radio-opaque compounds Il Farmaco; Edizione Pratica 38(6): 250-258
Stapert, E.M. 1972: Designing and monitoring a sterility test facility Bulletin of the Parenteral Drug Association 26(3): 129-138
Zañartu, J.; Navarro, C. 1968: Fertility inhibition by an injectable progestogen acting for 3 months. a clinical survey of 130 fertile women treated with norethisterone enanthate Obstetrics and Gynecology 31(5): 627-633
Et Al 1984: Comparative evaluation of contraceptive efficacy of norethisterone enanthate 200 milligram injectable contraceptive given every 2 or 3 months Contraception 30(6): 561-574
Et Al 1984: Comparative evaluation of contraceptive efficacy of norethisterone enanthate 200 milligram injectable contraceptive given every 2 or 3 months Contraception 30(6): 561-574
Martínez, G.H.; Castañeda, A.; Correa, J.E. 1998: Vaginal bleeding patterns in users of Perlutal, a once-a-month injectable contraceptive consisting of 10 mg estradiol enanthate combined with 150 mg dihydroxyprogesterone acetophenide. a trial of 5462 woman-months Contraception 58(1): 21-27
Rossi, G.; Solero, P. 1994: Cochlear implant: results of our experience - Implantation cochléaire: résultats de notre expérience - Cochlear implante: results of our experience Revue de Laryngologie, d'Otologie et de Rhinologie (1919) 115(4): 245-248